Genetic testing and counseling are crucial components of precision medicine in cancer care, enabling clinicians to deliver the right care, to the right patient, at the right time. i3 Health’s educational activity, Pathways to Precision: Integrating Genetic Counseling and Testing Into Cancer Care, provides a comprehensive foundation for incorporating these tools into practice. In this follow-up interview to the activity, co-chairs Dr. Filipa Lynce, Director of the Inflammatory Breast Cancer at Harvard Medical School, and Catherine Skefos, Certified Genetic Counselor at MD Anderson Cancer Center, share advances that have occurred in the field since the activity was recorded, including clinical trial updates and novel insights for clinicians.

Click here to complete the free CME/NCPD/CE activity: bit.ly/3HqXjpX

Additional Advances in Genetic Counseling and Testing in Cancer Care With Filipa Lynce, MD, and Catherine Skefos, MA, MS, CGC

Extrapulmonary neuroendocrine carcinomas (EP-NECs) are rare, aggressive tumors that present unique diagnostic and treatment challenges. In this accredited activity podcast, leading experts Dr. Andrew E. Hendifar and Dr. Danielle Hutchings from Cedars-Sinai Medical Center share practical strategies and emerging evidence on diagnosis, current therapies, and novel treatment targets.

Listen now to gain actionable insights and stay current on evolving approaches in EP-NECs!

Click the link to claim your CE credit:

Clinical Challenges in Extrapulmonary NEC: Expert Insights on Diagnosis, Treatment, and Emerging Targets

Transform your approach to CLL care with insights from clinical pharmacy expert, "Kelsey Marciano, PharmD, BCOP,UCHealth. This podcast unpacks the latest strategies for treatment selection and toxicity management—empowering oncology pharmacists to lead confidently, maximize patient outcomes, and deliver next-level care in the evolving era of oral targeted therapies.

🎧 Listen now and click the link to claim your CE credit!

Claim your credit here: https://bit.ly/4pGrLO5

🔗 Learn more and access continuing education activities: https://i3health.com

📲 Stay connected with i3 Health:

Twitter/X: https://bit.ly/42VAYs1
LinkedIn: https://bit.ly/3IMiCmv
Facebook: https://bit.ly/46JrQI2
YouTube: https://bit.ly/4pNhWxR
Instagram: https://bit.ly/4nUSNzE
Threads: https://bit.ly/3Wd6oq9

🎧 Subscribe to the i3 Health Podcast on your favorite streaming platform so you never miss the latest expert discussions!

Optimizing CLL Care: Pharmacist-Led Strategies for Treatment Selection and Toxicity Management

Transform your approach to CLL care with insights from clinical pharmacy expert, "Kelsey Marciano, PharmD, BCOP,UCHealth. This podcast unpacks the latest strategies for treatment selection and toxicity management—empowering oncology pharmacists to lead confidently, maximize patient outcomes, and deliver next-level care in the evolving era of oral targeted therapies.

🎧 Listen now and click the link to claim your CE credit!

Claim your credit here: bit.ly/4pGrLO5

🔗 Learn more and access continuing education activities: i3health.com

📲 Stay connected with i3 Health:

Twitter/X: https://bit.ly/3ITDaJV
Facebook: https://bit.ly/46wmwJo
YouTube: https://bit.ly/46PXLXx

🎧 Subscribe to the Oncology Data Advisor Podcast on your favorite streaming platform so you never miss the latest expert discussions!

Read the full article at: https://oncdata.com/travis-osterman-ai-informatics 

In this episode of Exploring AI in Oncology, Dr. Waqas Haque speaks with Dr. Travis Osterman, Director of Cancer Clinical Informatics at Vanderbilt-Ingram Cancer Center, about the evolving role of health informatics in oncology. Their conversation spans training pathways, precision oncology, data standards, AI integrations, and the strategies to promote adoption in both academic and community practices.

Charting New Paths in Oncology Informatics With Travis Osterman, DO, and Waqas Haque, MD, MPH

Psoriatic arthritis care is rapidly evolving, demanding multidisciplinary collaboration and timely access to evidence-based therapies for optimal patient outcomes. i3 Health's Multidisciplinary Task Force—Increasing Early Intervention and Optimizing Management in Psoriatic Arthritis—convened expert clinicians and a patient moderator to address real-world challenges in screening, diagnosis, comorbidity management, and therapeutic optimization.

In this follow-up interview, Archie Franklin, MBA, a psoriatic arthritis patient and Task Force moderator, shares insights on the discussion, the changing treatment landscape, and practical guidance for elevating standards of care.

Click here to view the Task Force and claim your CE credit: https://bit.ly/4h5NSKb

Additional Insights in Psoriatic Arthritis With Archie Franklin, MBA

Stay ahead in Systemic Mastocytosis (SM) treatment! This interview, featuring Dr. Mariana Castells, explores the latest advancements in patient-centered care, including new drug approvals, multidisciplinary approaches, and crucial diagnostic updates. Learn how to shorten diagnosis times and improve long-term patient quality of life. Stay tuned after the interview to hear Module 1 of the podcast series, "Mastering Systemic Mastocytosis: From Early Detection to Tailored Treatment Strategies"

Don't forget to claim your credit after the episode!

Click on the link to claim your credit for module 1: bit.ly/3Y3ivHM
Click here to continue listening to Module 2 of this podcast series: bit.ly/43VoFNP

Additional Advances in Systemic Mastocytosis Research and Clinical Trials With Mariana Castells, MD, PhD + Module 1

Stay ahead in Systemic Mastocytosis (SM) treatment! This interview, featuring Dr. Mariana Castells, explores the latest advancements in patient-centered care, including new drug approvals, multidisciplinary approaches, and crucial diagnostic updates. Learn how to shorten diagnosis times and improve long-term patient quality of life. Stay tuned after the interview to hear Module 2 of the podcast series, "Mastering Systemic Mastocytosis: From Early Detection to Tailored Treatment Strategies"

Don't forget to claim your credit after the episode!

Click on the link to claim your credit for module 2: bit.ly/43VoFNP

Additional Advances in Systemic Mastocytosis With Mariana Castells, MD, PhD + Module 2

Christoph U. Correll, MD, Professor of Psychiatry and Molecular Medicine at the Zucker School of Medicine at Hofstra/Northwell and Chair of Child and Adolescent Psychiatry at Charité University in Berlin, is currently chairing i3 Health’s four-part educational activity, Schizophrenia Update: Navigating the Latest in Research and Treatment. In this interview, he shares recent updates in schizophrenia research and explains why education is so critical for clinicians to optimize their patients’ outcomes.

Click here to listen to the full activity podcasts! 

Module 1: https://bit.ly/3JsEYKf
Module 2: https://bit.ly/436dYa5
Module 3: https://bit.ly/47fkz4p
Module 4: https://bit.ly/4oflWWZ

Additional Insights in Schizophrenia Research and Clinical Trials With Christoph U. Correll, MD

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

Additional Advances in Genetic Counseling and Testing in Cancer Care With Filipa Lynce, MD, and Catherine Skefos, MA, MS, CGC

Oncology Data Advisor®

Related tracks